Rac1 as a Target to Treat Dysfunctions and Cancer of the Bladder

Rac1 as a Target to Treat Dysfunctions and Cancer of the Bladder

Bladder pathologies, very common in the aged population, have a considerable negative impact on quality of life. Novel targets are needed to design drugs and combinations to treat diseases such as overactive bladder and bladder cancers. A promising new target is the ubiquitous Rho GTPase Rac1, frequ...

Full description

Bibliographic Details
Main Authors: Vincent Sauzeau, Julien Beignet, Christian Bailly
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Biomedicines
Subjects:
bladder cancer
Rho GTPase
bladder dysfunction
Rac inhibitors
metastasis
overactive bladder
Online Access:https://www.mdpi.com/2227-9059/10/6/1357

Similar Items

Similar Items